On Apr. 9, 2025, a team of neuro scientists scientists published findings from the Machine Intelligence from Cortical…
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
On Apr. 2, 2025, Revvity announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure…
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
On Mar. 3, 2025, Revvity announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support…
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
On Feb. 18, 2025, Hologic announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…
On Feb. 11, 2025, Novartis announced an agreement to acquire Anthos Therapeutics, a Boston-based, privately held, clinical-stage biopharmaceutical…
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
On Jan. 30, 2025, the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’s Journavx (suzetrigine) 50 milligram…
On Jan. 27, 2025, researchers at the Broad Institute of MIT and Harvard, along with collaborators at Calico…
On Jan. 22, 2025, researchers at Dana-Farber Cancer Institute announced they have developed a breakthrough method to detect…
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
On Oct. 15, 2024, Massachusetts Governor Maura Healey and the Massachusetts Life Sciences Center (MLSC) announced $21.4 million…
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
On Oct. 7, 2024, The Nobel Foundation announced that Victor Ambros from Harvard University and Gary Ruvkun from…
On Sept. 25, 2024, a study led by scientists at Harvard Medical School announced they had developed an…
On Aug. 14, 2024, a study co-led by Mass General Brigham found that one in four patients with…
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…